Evaluation of an alternative dosing regimen of a J-5 mastitis vaccine against intramammary Escherichia coli challenge in nonlactating late-gestation dairy cows

19Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

Abstract

The objective of the study was to evaluate the efficacy of an alternative vaccination regimen of a J-5 bacterin against intramammary Escherichia coli challenge in nonlactating late-gestation dairy cows. The parameters analyzed to assess the effect of vaccination were milk yield, milk conductivity, somatic cell count, J-5-specific serum IgG titers, and clinical signs. Twenty multiparous Holstein cows from the Cornell teaching and research dairy herd were paired by days in milk and were randomly selected to receive either the alternative off-label regimen of commercial J-5 bacterin or act as nonvaccinated controls. Cows received a first dose of bacterin 15. d before dry off, a second dose with the same product at the day of dry off, and the third dose 2 wk after dry off. The cows in both groups were challenged 10 d before the expected calving date. Serum IgG (total, IgG1 and IgG2) levels were higher in vaccinates compared with control cows. Eighty-five percent of challenged quarters became infected between both groups of animals. Eight of the 10 vaccinated and 9 of the 10 control cows showed signs of clinical mastitis postfreshening. A non-severe clinical mastitis was observed 24 to 48. h postparturition, characterized by flakes or clots in milk and mild swelling or pain. Off-label vaccination did reduce the clinical severity of clinical mastitis in the vaccinated group of cows as evidenced by reduced California mastitis test score, fewer flakes and lower overall clinical mastitis score. No significant differences between vaccinated and control groups were detected for rectal temperature. In conclusion, the alternative off-label vaccination scheme used in our study and evaluated in a novel E. coli challenge model did not prevent new intramammary infections but reduced clinical severity of experimentally induced E. coli mastitis. © 2013 American Dairy Science Association.

References Powered by Scopus

Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells

877Citations
N/AReaders
Get full text

Incidence rate of clinical mastitis on Canadian dairy farms

381Citations
N/AReaders
Get full text

Effect of pathogen-specific clinical mastitis on milk yield in dairy cows

313Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Causes, types, etiological agents, prevalence, diagnosis, treatment, prevention, effects on human health and future aspects of bovine mastitis

88Citations
N/AReaders
Get full text

An investigation of the efficacy of a polyvalent mastitis vaccine using different vaccination regimens under field conditions in the United Kingdom

64Citations
N/AReaders
Get full text

Immune response after an experimental intramammary challenge with killed Staphylococcus aureus in cows and heifers vaccinated and not vaccinated with Startvac, a polyvalent mastitis vaccine

21Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Gurjar, A. A., Klaessig, S., Salmon, S. A., Schukken, R. J., & Yancey, Y. H. (2013). Evaluation of an alternative dosing regimen of a J-5 mastitis vaccine against intramammary Escherichia coli challenge in nonlactating late-gestation dairy cows. Journal of Dairy Science, 96(8), 5053–5063. https://doi.org/10.3168/jds.2012-6456

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 24

69%

Researcher 6

17%

Professor / Associate Prof. 3

9%

Lecturer / Post doc 2

6%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 20

53%

Veterinary Science and Veterinary Medic... 13

34%

Medicine and Dentistry 3

8%

Computer Science 2

5%

Save time finding and organizing research with Mendeley

Sign up for free